Prkca is a Th17 cell–selective kinase regulating IL-17A production (30) and acts as a tumor suppressor in the intestine (31); reduced expression is associated with other immune-mediated phenotypes, including multiple sclerosis (32). Here, PRKCA is linked to neoplasm.